top of page
Group 51.png

Qualifying participants will be provided with a diagnostic test for SIBO, and will follow a 8 week course of probiotics (or placebo), with sampling for microbiome changes at several time points. 

Probiotic Efficacy in Bloating

iStock-1755521531 (1).jpg

STUDY DESIGN

A double-blind, randomized, placebo-controlled clinical study in patients with diagnosed or suspected Small Intestinal Bacterial Overgrowth (SIBO).

A Study in Partnership with Lallemand Health Solutions




Qualifying participants will be provided with a diagnostic breath test for small bacterial overgrowth, complete daily and weekly questionnaires, will follow an 8 week course of probiotics (or placebo), with sampling for microbiome changes at several time points. 

Logo - LHS.png

Ethics approval ID: HREBA.CTC-23-0061

TO BE ELIGIBLE FOR THE STUDY, YOU MUST MEET AT LEAST THE FOLLOWING CRITERIA

18 - 55 years of AGE

Suffer from bloating, diarrhea or abdominal pain

Follow an 8 week 
course of Probiotics

Male or female

Upon enrollment you will receive a diagnostic Breath Test to confirm your eligibility. 

Formulation designed for SIBO
note: some participants will receive a placebo

This study is now recruiting. 

During a screening call, our trained team of clinical coordinators will review all elements of the study, including its duration and time commitment, participant compensation and other benefits if any, procedural risks and your eligibility. 

Didn’t find a study that suits you today?

Register to be notified about upcoming studies.

Terms and Conditions: Your information will only be used to contact you about opportunities to join future clinical studies. You can unsubscribe at any time. Your information will not be shared.

Sign up by completing the form below.

bottom of page